Surface Expression of Kynurenine 3-Monooxygenase Promotes Proliferation and Metastasis in Triple-Negative Breast Cancers
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by SAGE Publications in Cancer Control
- Vol. 28
Abstract
Kynurenine 3-monooxygenase (KMO) is the pivotal enzyme in the kynurenine pathway and is located on the mitochondrial outer membrane. The dysregulation of KMO leads to various neurodegenerative diseases; however, it is rarely mentioned in cancer progression. Our previous study showed that KMO overexpression in canine mammary gland tumors (cMGT) is associated with poor prognosis in cMGT patients. Surprisingly, it was also found that KMO can be located on the cell membranes of cMGT cells, unlike its location in normal cells, where KMO is expressed only within the cytosol. Since cMGT and human breast cancer share similar morphologies and pathogenesis, this study investigated the possibility of detecting surface KMO in human breast cancers and the role of surface KMO in tumorigenesis. Using immunohistochemistry (IHC), flow cytometry (FC), immunofluorescence assay (IFA), and transmission electron microscopy (TEM), we demonstrated that KMO can be aberrantly and highly expressed on the cell membranes of breast cancer tissues and in an array of cell lines. Masking surface KMO with anti-KMO antibody reduced the cell viability and inhibited the migration and invasion of the triple-negative breast cancer cell line, MDA-MB-231. These results indicated that aberrant surface expression of KMO may be a potential therapeutic target for human breast cancers.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 102-2313-B-002-031-MY3)
This publication has 31 references indexed in Scilit:
- Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemiaBlood, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- p53-Dependent BRCA1 Nuclear Export Controls Cellular Susceptibility to DNA DamageCancer Research, 2011
- Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates NeurodegenerationCell, 2011
- Molecular Stratification of Triple-Negative Breast CancersThe Oncologist, 2010
- Aberrant nucleocytoplasmic localization of the retinoblastoma tumor suppressor protein in human cancer correlates with moderate/poor tumor differentiationOncogene, 2007
- Triple-Negative Breast Cancer: Clinical Features and Patterns of RecurrenceClinical Cancer Research, 2007
- The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break RepairMolecular Cancer Research, 2005
- BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retentionExperimental Cell Research, 2004
- Roles of BRCA1 and its interacting proteinsBioEssays, 2000